Applications of (1R,2S)-2-Amino-1,2-Diphenylethanol in Industrial Manufacturing

As a direct manufacturer of (1R,2S)-2-Amino-1,2-Diphenylethanol, we focus on supplying this chiral building block for downstream applications that require enantiopure intermediates and specialty synthesis. Our production quality supports advanced industries where regulatory compliance, precise formulation, and process control are critical. Explore the specific industrial uses and integration details below.

1. Chiral Intermediate in Pharmaceutical Active Ingredient Synthesis

Pharmaceutical manufacturers rely on (1R,2S)-2-Amino-1,2-Diphenylethanol as a critical intermediate for the preparation of specific chiral active pharmaceutical ingredients (APIs), particularly beta-blockers and related compounds. Its well-defined stereochemistry supports targeted synthesis pathways, reducing downstream resolution steps and supporting batch-to-batch consistency required by global compliance frameworks.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for APIs
• 21 CFR Part 210/211 (FDA cGMP)
• EDQM/European Pharmacopoeia monographs for APIs
• PIC/S Guide to GMP for Medicinal Products

Typical usage ratio

• Typically 0.12–0.38 molar equivalents relative to final API, adjusted according to the stereochemical purity requirement and reaction stoichiometry.

Downstream process integration

• Introduced during early-stage chiral synthesis steps after initial substrate formation; often involved in asymmetric reductive amination or nucleophilic addition, followed by purification prior to coupling or completion steps.

Final product types

• Chiral beta-blockers (e.g., Nebivolol)
• Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
• Pharmaceutical intermediates for antihypertensive drugs

2. Catalyst Ligand Precursor for Asymmetric Hydrogenation in Fine Chemicals

Producers of fine chemicals and advanced organometallic catalysts utilize this material as a precursor in the synthesis of chiral ligands for asymmetric hydrogenation. Its rigid diastereomeric structure contributes to high enantioselectivity during late-stage reduction processes, which is crucial for maintaining overall molecular precision in complex fine chemical production.

Industry compliance standards

• ISO 9001:2015 Quality Management for Chemical Production
• REACH Annex II for chemical agent handling
• Responsible Care® Management System

Typical usage ratio

• Employed at 1.0–5.0 mol% relative to metal center in ligand synthesis; further adjusted based on ligand-metal complexation efficiency and end-use enantiomeric excess requirements.

Downstream process integration

• Reacted with phosphine or imine moieties in chiral ligand synthesis prior to complexation with transition metal catalysts; batch or continuous processes may be employed based on production scale.

Final product types

• Chiral phosphine ligands for asymmetric catalysis
• Enantioselective catalyst systems for fine and specialty chemicals
• Building blocks for high-value agrochemical intermediates

3. Optical Resolution Agent in Specialty Amino Alcohol Production

Chemical processing plants employ (1R,2S)-2-Amino-1,2-Diphenylethanol as an optical resolution agent in the manufacture of high-purity amino alcohols. By forming diastereomeric salts or complexes, this material facilitates the separation of enantiomers critical to applications in pharmaceutical and agrochemical synthesis, where downstream biological activity hinges on single-enantiomer forms.

Industry compliance standards

• US Pharmacopeia (USP) monographs for chiral reagents
• ISO 17025:2017 Laboratory Quality for QC methods
• European Pharmacopoeia 2.2.40 (chiral purity by chromatography)

Typical usage ratio

• Used at equimolar or slight molar excess (1.0–1.15:1) versus racemic substrate, with adjustments based on crystallization system solubility and target yield of optically pure fraction.

Downstream process integration

• Mixed directly with racemic amino acids or amines during resolution stage, often in solution, followed by filtration and/or recrystallization; unreacted excess recovered and recycled.

Final product types

• Optically active amino alcohols
• Chiral amine intermediates for further synthesis

4. Chiral Derivatization Reagent in Analytical Reference Materials

Producers of analytical standards and reference materials for chromatographic analysis utilize (1R,2S)-2-Amino-1,2-Diphenylethanol as a derivatization agent for improving enantiomeric separation and detection. Its rigid chiral backbone enables high differentiation in LC and GC methods, facilitating accurate quantification and quality control in pharmaceutical assay laboratories.

Industry compliance standards

• ISO 17034:2016 for Reference Material Producers
• FDA GLP 21 CFR Part 58
• USP <1225> Validation of Compendial Procedures

Typical usage ratio

• Employing 1–2 equivalents per analyte, with precise ratio selected to maximize derivatization completion and achieve clear chromatographic resolution without excessive background signal.

Downstream process integration

• Added in derivatization step prior to injection on chiral stationary phase columns; reaction conditions tailored for rapid reaction while preventing racemization of target analytes.

Final product types

• Certified analytical reference standards
• Custom derivatized QC samples for HPLC/GC enantiomeric assays